Literature DB >> 21714121

Cell death-independent functions of granzymes: hit viruses where it hurts.

Robert van Domselaar1, Niels Bovenschen.   

Abstract

Granule exocytosis by cytotoxic lymphocytes is the key mechanism of our immune response to eliminate virus-infected cells. These lytic granules contain the pore-forming protein perforin and a set of five serine proteases called granzymes (GrA, GrB, GrH, GrK, GrM) that display distinct substrate specificities. Granzymes have mostly been studied for their ability to induce cell death. However, viruses have evolved many inhibitors to effectively block apoptosis. Evidence is emerging that granzymes also use noncytotoxic strategies to inhibit viral replication and potential viral reactivation from latency. Granzymes directly cleave viral or host cell proteins that are required in the viral life cycle. Furthermore, granzymes induce a pro-inflammatory cytokine response to create an antiviral environment. In this review, we summarize and discuss these novel strategies by which the immune system counteracts viral infections, and we will address the potential therapeutic applications that could emerge from this intriguing mechanism.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21714121     DOI: 10.1002/rmv.697

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  13 in total

Review 1.  Granzyme M: behind enemy lines.

Authors:  S A H de Poot; N Bovenschen
Journal:  Cell Death Differ       Date:  2014-01-10       Impact factor: 15.828

2.  Granzyme M targets host cell hnRNP K that is essential for human cytomegalovirus replication.

Authors:  R van Domselaar; S A H de Poot; E B M Remmerswaal; K W Lai; I J M ten Berge; N Bovenschen
Journal:  Cell Death Differ       Date:  2012-10-26       Impact factor: 15.828

Review 3.  Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis.

Authors:  Melissa Bowerman; Thierry Vincent; Frédérique Scamps; Florence E Perrin; William Camu; Cédric Raoul
Journal:  Front Cell Neurosci       Date:  2013-11-19       Impact factor: 5.505

Review 4.  Immune Responses to Influenza Virus and Its Correlation to Age and Inherited Factors.

Authors:  Azadeh Bahadoran; Sau H Lee; Seok M Wang; Rishya Manikam; Jayakumar Rajarajeswaran; Chandramathi S Raju; Shamala D Sekaran
Journal:  Front Microbiol       Date:  2016-11-22       Impact factor: 5.640

5.  Dose dependent activation of retinoic acid-inducible gene-I promotes both proliferation and apoptosis signals in human head and neck squamous cell carcinoma.

Authors:  Jingzhou Hu; Yue He; Ming Yan; Chao Zhu; Weimin Ye; Hanguang Zhu; Wantao Chen; Chenping Zhang; Zhiyuan Zhang
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

6.  Hantavirus-infection confers resistance to cytotoxic lymphocyte-mediated apoptosis.

Authors:  Shawon Gupta; Monika Braun; Nicole D Tischler; Malin Stoltz; Karin B Sundström; Niklas K Björkström; Hans-Gustaf Ljunggren; Jonas Klingström
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

Review 7.  Evasion of influenza A viruses from innate and adaptive immune responses.

Authors:  Carolien E van de Sandt; Joost H C M Kreijtz; Guus F Rimmelzwaan
Journal:  Viruses       Date:  2012-09-03       Impact factor: 5.048

8.  Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus.

Authors:  Nedzad Music; Adrian J Reber; Jin Hyang Kim; Ian A York
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

Review 9.  Host Immune Response to Influenza A Virus Infection.

Authors:  Xiaoyong Chen; Shasha Liu; Mohsan Ullah Goraya; Mohamed Maarouf; Shile Huang; Ji-Long Chen
Journal:  Front Immunol       Date:  2018-03-05       Impact factor: 7.561

Review 10.  Influenza Virus-Host Co-evolution. A Predator-Prey Relationship?

Authors:  Konstantinos Voskarides; Eirini Christaki; Georgios K Nikolopoulos
Journal:  Front Immunol       Date:  2018-09-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.